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Clinicians have long recognized the potentially serious
manifestations of extreme bradycardia. However, even
marked bradycardia can often be physiologic, and in the
presence of impaired ventricular function may offer im-
portant compensatory hemodynamic effects. Disorders
of the sinoatrial node producing bradycardia include
failure of impulse formation, sinoatrial conduction block,
concealed sinus-perinodal reentry, carotid sinus hyper-
sensitivity and the constellation of brady- and tachyar-
rhythmias that compose the "sick sinus syndrome."
Bradycardia can also result from intraatrial block, atrio-
ventricular nodal block or infranodal block. In addition,
paroxysmal supraventricular tachyarrhythmias may
produce concealment into the atrioventricular junction
and simultaneous suppression of sinus node rhythmicity,
resulting in long pauses. Pseudobradycardias manifest-
ing as slow peripheral pulse rates can result from fre-
Almost no departure from regular sinus rhythm is without
its effect on the performance of the heart (I). Although
sinus bradycardia has been defined for adults as sinus rhythm
with a rate of less than 60 beats/min, slower heart rates are
frequently encountered in a variety of normal physiologic
circumstances and pathologic conditions. Even markedly
bradycardic rhythms can be well tolerated provided the min-
ute volume is sufficient to meet ongoing metabolic and
functional requirements .
Physiology
The slowing of the heart rate prolongs the ventricular filling
period and engenders ventricular dilation, which by the Frank-
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quent, nonconducted early atrial premature beats, from
ventricular bigeminy or rJ,IDS of ventricular extrasystoles
or from mechanical alternans.
Cardiac pacemakers play an important role in the
management of patients with severe symptoms attrib-
utable to bradyarrhythmias. However, excessive use of
pacemakers and the inappropriate selection of physio-
logically unfavorable pacemaker systems should be
avoided. Frequently, patients who are only mildly symp-
tomatic with bradycardia should not receive a cardiac
pacemaker because the prognosis is favorable. Patients
with the tachy-bradycardia syndrome often require both
pharmacologic and pacemaker therapy. In selected pa-
tients electrophysiologic testing may be helpful, but the
majority of patients are best managed by careful atten-
tion to the history, electrocardiogram and ambulatory
electrocardiographic recordings.
Starling mechanism produces an increase in stroke volume
so that minute cardiac output can remain normal despite the
marked slowing of the heart rate . However, the normal
ventricle can apparently accommodate no more than ap-
proximately 250 ml. Consequently , even with maximal ac-
commodation, an ample filling time and an ejection fraction
of 80%, a marginal minute output of only 4 liters/min will
require a heart rate of at least 20 beats/min. In the presence
of exertion or emotional activit y, where an increase in the
minute output is mandatory, circulatory insufficiency will
develop even in the presence of rates greater than 20 beats/
min . If the heart rate further decrea ses, a " compensatory"
increase in stroke volume can no longer keep pace with even
the minimal required resting minute volume . However ,
bradycardia can also be a manifestation of normal physi-
ology in a healthy heart as well as a protective mechanism
in the presence of heart disease . For example, a slower heart
rate can protect against serious ventricular arrhythmias in
the presence of an acute myocardial infarction (2) or serve
as a mechanism to reduce oxygen utilization in the presence
of ischemic heart disease (3) .
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Clinical Manifestations
The clinical manifestations of bradycardia were first de-
scribed in the 18th century. The observations of Derbezius
(1719), Morgagni (1761), Sepens (1793), Adams (1827),
Burnett (1827) and Stokes (1846) were extensively reviewed
by Major (4). Accordingly, attacks of syncope with or with-
out convulsive seizures due to severe bradycardia «
20 beats/min) or prolonged asystole (5 to 10 seconds or
more) are often referred to as either Stokes-Adams episodes
or, more correctly, the Morgagni-Stokes-Adams syndrome
(5). These early clinicians reported that syncope is accom-
panied by an abnormal pulse rate that is usually slow be-
tween attacks and even slower or absent during attacks (4).
Furthermore, they noted a definite relation between the marked
slowing of the pulse rate and the attacks. Milder manifes-
tations related to bradycardia may be present when periods
of asystole last only 2 to 5 seconds. Brief periods of weak-
ness, dizziness or faintness secondary to bradyarrhythmias
can often be misinterpreted as momentary sleep or confu-
sion. especially in persons with other cardiovascular or cere-
brovascular impairments. such as cerebral arteriosclerosis
(6).
Paroxysms of profound bradycardia or prolonged asys-
tole are apparently the cause of only a fraction of the epi-
sodes of cardiac syncope. Such episodes may also result
from tachyarrhythmias, ventricular fibrillation. vasovagal
reactions and profound mechanical ventricular dysfunction.
Curiously, bradycardia of less than 30 beats/min appears to
be better tolerated than tachycardia at rates greater than 150
beats/min, with regard to both precordial discomfort and
circulatory disturbances. The sudden severe reduction in
forward blood flow associated with acute or transient brady-
cardia results in immediate cerebral manifestations. These
signs occur before the more insidious and slowly developing
sequelae of bradycardia-induced low output. manifested by
fatigue. dyspnea and congestive heart failure have a chance
to develop (6).
Neurologic symptoms engendered by bradycardia. in-
eluding syncope. dizziness and memory lapse, can be in-
capacitating and result in serious injury or death. especially
in persons working in potentially hazardous environments
or operating motor vehicles. dangerous machinery or air-
craft. Furthermore, the occurrence of disability, accident or
death in a patient with known periods of bradycardia could
have medicolegal consequences for the physician, even if
the event was unrelated to a disturbance in heart rhythm or
rate.
Cardiac Pacing
The introduction of cardiac pacing by Zoll (7) in 1952 of-
fered a direct approach to the correction of bradycardia and
was an important advance in the management of sympto-
matic patients. However. available data suggest that the
prognosis for patients with bradycardia not associated with
severe symptoms is favorable without intervention (8).
Therefore. pacemaker implantation should probably be re-
stricted to symptomatic persons in whom periods of bra-
dycardia closely coincide with symptoms (8). Furthermore.
the medical profession in the United States has been sharply
criticized for implanting too many pacemakers for brady-
cardia as well as other cardiac arrhythmias, as judged by
implantation data from other English-speaking countries en-
joying comparable levels of sophisticated and comprehen-
sive medical care (9,10). Possible causes for the seemingly
excessive use of cardiac pacing in this country can be traced
to the simplicity of the procedure. its availability in virtually
every community hospital. the low risk of implantation, the
fear of legal liability and. most important, misinterpretation
of published data concerning disorders of impulse formation
and conduction as causes of incapacitating symptoms or life-
threatening cardiovascular events.
It is the purpose of this discussion to review the clinical
significance and management of bradycardia. Because many
electrocardiographic records demonstrating the common
causes of bradyarrhythmia have been published (11-16).
only selected examples relevant to this review have been
chosen for illustration.
Bradycardia: How Slow Is Slow?
Both sinus rates of less than 40 to 50 beats/min and bra-
dycardia resulting from normal sinus rhythm with atrioven-
tricular conduction delay and block have been described in
normal persons and especially in trained athletes (Fig. 1)
(17). Recently. Talan et al. (18) observed minimal heart
rates during sleep as slow as 31 to 43 beats/min with sinus
pauses as long as 1.6 to 2.8 seconds in a group of 20 long
distance runners aged 19 to 28 years. Furthermore. 8 of
these 20 men had one or more episodes of Mobitz type I
second degree atrioventricular block documented during
ambulatory 24 hour electrocardiographic recording. Bra-
dycardia in athletes has generally been attributed to in-
creased vagal tone and decreased sympathetic activity, and
even profound asymptomatic bradycardia in well condi-
tioned athletes can be considered a normal variant. Presum-
ably, episodes of atrioventricular block reflect a more marked
autonomic effect on the atrioventricular node than on the
sinoatrial node in susceptible persons.
Sinus bradycardia has been a generally accepted' 'phys-
iologic'; finding in older persons. This concept was recently
challenged by Kostis et al. (19). who found a reduction in
maximal heart rate achieved during daily activities or ex-
ercise was associated with a lower exercise tolerance in older
persons. The heart rate at rest was not reduced and the heart
rate response to submaximal exercise was exaggerated rather
than attenuated. In another group of elderly patients eval-
uated with ambulatory monitoring, 98 patients. apparently
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Figure l. Lead Vs rhythm strips taken
from a 28 year old athlete, Upper
strip: Sinus arrhythmia and brady-
cardia are seen with cycle lengths as
long as 2,8 seconds, Lower strip:
Lead Vs taken during mild exercise,
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free of heart disease and 75 years of age or older, most
frequently demonstrated a heart rate of 50 to 100 beats/min
(20). Only II of the 98 subjects had a heart rate at rest of
less than 50 beats/min. Furthermore, although ectopic car-
diac rhythms and tachycardias were relatively common in
these apparently healthy elderly people, prolonged marked
ventricular pauses or bradycardias were only infrequently
recorded.
Alternatively, on the basis of a 7 year follow-up study
of active middle-aged men, Hinkle et al. (21) suggested that
slow heart rates recorded with ambulatory monitoring were
associated with an increased risk of cardiac death in men
with coronary heart disease, pulmonary disease or hyper-
tension. Is bradycardia in itself dangerous? The better life
quality and possibly better prognosis of a person who in-
dulges in daily physical training and thus manifests a lower
resting heart rate may render sinus bradycardia at rest very
benign.
Finally, bradyarrhythmias may also present a problem
in the management of children and infants. In particular,
bradycardic episodes have been linked to severe apneic pe-
riods in newborn infants and some infants with a "near-
miss crib death" and are of current investigative interest
(22,23).
Failure of Sinus Node Impulse
Formation or Conduction
Differentiating between extreme but physiologic sinus bra-
dycardia and sinus node dysfunction may be difficult (Fig.
2). Disorders of the human sinoatrial node pacemaker were
first reported by Wenckebach (24) and Laslett (25). Careful
scrutiny of arterial and venous pulse recordings published
as early as 1899 by Wenckebach (26) clearly demonstrates
Figure 2. Three cases of sinoatrial block. Upper strip: Second degree
sinoatrial Wenckebach block with a 4:3 sinoatrial conduction ratio. Second
strip: "Escape capture bigeminy" produced by sinus node dysfunction.
probably second degree sinoatrial block with junctional escape beats. Junc-
tional beats I. 3, 5 and 7 are followed by ventricular capture beats, Third
and fourth strips: Sinoatrial block is seen, as well as so-called escape
capture bigeminy, The last beat in the third strip is reproduced as the first
QRS complex in the fourth strip,
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that the " quickening of the pulse" and the pattern of ar-
rhythm ia he described were a result of sinoatrial rather than
atrioventri cular block . Hence , Wenckebach was probabl y
the first to describe sinoatrial block in human beings, al-
though the "Wenckebach phenom enon " is usually asso-
ciated with Mob itz type I seco nd degree atrioventricular
block.
Sick Sinus Syndrome
Although abnormalities of both sinus node impulse for-
mation and conduction are relativel y common, they have
often gone unrecognized or been misdiagnosed. With the
advent of cardiac pacing, interest in disorders of the sinus
node has increased. The term "sick sinus syndrome" has
been used to encompass a wide variety of abnormalities of
impulse formation and conduction involving the sinus node,
as well as other specialized cardiac conduction tissue and
potential subsidiary pacemakers (12,27-29 ). Manifestations
ofthe sick sinus syndrome may include : I) persistent , severe
and inappropriate sinus bradycardia: 2) cessation of sinus
rhythm , sinus pauses or sinus arrest for intervals during
which there is also failure of subsidiary escape pacemakers;
3) replacement of the sinus rhythm by an ectopic atrial or
junctional pacemaker; 4) paroxysmal or chronic atrial fi-
brillation , or atrial standstill with total absence of sinus node
activity; 5) susceptibility to paroxysmal supraventricular ar-
rhythmias, including atrial fibrillation and junctional tachy-
cardias; 6) prolonged suppressio n of sinus rhythm after
spontaneous or electrical conversion from atrial fibrillation
or other supraventricular tachycard ias; 7) episodes of si-
noatrial exit block (that is, abnormal sinus node conduction)
not related to excessive drug (for example. digoxin) therap y;
and 8) carotid sinus hypersensitivity resulting in prolong ed
asystole or high grade atrioventricular nodal block, or both.
The sick sinus syndrome has protean presentations and
variable degrees of severity. It occurs idiopathically and as a
result of various cardiomyopathic, degenerative or ischemic
processes and often requires escalating therapeutic regi-
mens. Typically , paroxysmal atria l flutter or fibrillation is
first treated with drugs (such as digoxin, beta-receptor block-
ing agents and. more recentl y, verapamil) to slow atrio-
ventricular nodal conduction . As episodes increase in fre-
quency, these same drugs may be prescribed prophylacti-
cally. After subsequent recurrences of arrhythmia. quinidine
or other class I antiarrhythmi c drug s may be added. How-
ever, at some point in this pharmacologic hierarchy either
primary or post-tachycardia symptomatic bradyarrhythmias
often become more incapacitating than the tachy-
arrhythmias . and permanent pacemaker implantation fol-
lows . This full-blown constellation of complex tachy- and
bradyarrhythmias is often referred to as the tachy-brady-
cardia syndrome, which is further discussed later.
Role of cardiac pacing. In the United States approxi-
mately 40% of all pacemakers are implanted primarily for
sinoatrial disease , accord ing to the World Survey of Cardiac
Pacing in 1978 (30). Because many patient s with this disease
have normal atrioventricular and ventriculoatrial conduc-
tion , the use of ventricular pacing systems may occasionally
engender unexpectedly serious hemod ynamic consequences
and symptoms owing to retrograde conduction and inap-
propri ate ventriculoatrial sequencing, which is now iden-
tified as a cause of the so-ca lled pacem aker sy ndrome
(Fig . 3) (31). Such sequencing can result in atrial contraction
against closed atrioventricular valves. with subsequent pul-
monary and systemi c venous regurgitation . inadequate ven-
tricular filling and abnormal neurohumoral reflexes (31).
The consideration of an appropriate pacemaker system can
be particularly pertinent in patient s manifesting carotid sinus
hyper sensitivity. Some of these patients apparently develop
syncope not merely from a slowing of rate, but also from
vasodepressor effects. In such patient s, demand ventricular
pacing is often inadequate . Although atrioventricular se-
quenti al pacing is usually of benefit , certain patient s will
cont inue to suffer from symptomatic hypotension during
carotid sinus stimulation (Fig . 4). In general, we prefer to
evaluate the hemod ynamic effects of ventricular versus atrial
versus atrioventricular sequential pacing (and at multiple
atrioventricular intervals) before permanent pacemaker im-
plantation in any patient who will frequently be pacemaker-
dependent. We also avoid ventricular pacing if bothersome
symptoms result or the blood pressure decreases by more
than 20 mm Hg in a previously normotensive patient.
Evaluation of Sinus Node Function
Overall, the prognosis for the great majority of patient s with
bradycardia or asymptomatic sinus node dysfunction is good
Figure 3. Leads II. VI and aortic pressure tracing. During sinus rhythm
(left portion) the peak systolic pressure is 130 mm Hg. With the onset of
ventricular pacing (PACE) there was a marked decrease in blood pressure
to 84 mm Hg, which produced weakness and fainting.
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.CSPFigure 4. A, Effect of carotid sinus pressure on
sinus node function. The figure is arranged as
follows: leads II and VI, right artrial electrogram
(RAE) and aortic root pressure tracing (AO).
After carotid sinus pressure (CSP) there is a 6
second period of asystole. Time lines are at I
second intervals; aortic pressure is shown in mm
Hg. B, Strips arranged as in A (excluding the
right atrial electrogram) demonstrating the vaso-
depressor effect of carotid sinus pressure in the
same patient. The heart is now paced by an AV
sequential pacemaker and when carotid sinus
pressure is applied (center of the strip). the peak
systolic aortic pressure decreases from 110 to 88
mm Hg. There is no change in the atrial or ven-
tricular rate because AV sequential pacing was
maintained throughout the procedure.
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without therapeutic intervention and therefore further studies
are not necessarily indicated in most of these patients. Fur-
thermore, most of the patients with more severe or symp-
tomatic bradyarrhythmias die of cardiovascular problems
unrelated to sinus node disease, such as congestive heart
failure and serious ventricular arrhythmias (27,30).
Holter ambulatory monitoring. Disorders of the sinus
node can often be identified by combining use of routine
electrocardiographic recordings with use of 24 hour long-
term electrocardiographic ambulatory (Holter) monitoring
or event recorders, especially at the time when symptoms
are present. There is no substitute for recording typical
symptomatic episodes and determining that a specific rhythm
or rate disturbance occurred consistently in association with
these episodes (32). More often, a variety of rhythm dis-
turbances occur inconsistently with poorly documented
symptoms. Unfortunately, misinterpretation of the Holter
monitor strips may also lead to inappropriate pacemaker
insertion simply because the interpretation of a bradycardic
event is identified in an official report as sick sinus syndrome
or sinus arrest. "Pseudobradycardia" has also been reported
during Holter monitoring as a result of disconnection of an
electrode or sticking of the tape to the capstan during replay,
which produces slowing and transient acceleration of the
tape speed during recording (33). However, the importance
of documenting spontaneous clinical episodes in the diag-
nosis of sinus node dysfunction cannot be overemphasized;
every reasonable effort should be made to use the electro-
cardiogram, Holter recordings, event recorders and, occa-
sionally, exercise testing to document the frequency, se-
verity and relation of bradycardic episodes to symptoms
before subjecting patients to either pacemaker insertion or
invasive electrophysiologic tests (32). In particular, the pos-
sible effects of drugs (antiarrhythmic, antisympathetic or
cholinergic agents, for example) on the sinus node, partic-
ularly those potentially affecting the autonomic nervous sys-
tem, should be carefully considered (34). Carotid sinus mas-
sage may also prove useful in selected patients if performed
properly and with appropriate electrocardiographic moni-
toring (Fig. 4A).
Invasive electrophysiologic testing. Invasive studies
utilizing electrophysiologic testing may be necessary in some
instances to identify disorders of sinus node function in
patients who are seriously symptomatic and in whom non-
invasive studies fail to document a suspected electrophys-
iologic disorder (35-37). Notably, provocative intracardiac
electrophysiologic testing will often reveal derangements
other than sinus node dysfunction as the cause of recurrent
symptoms in patients with suspected bradyarrhythmias; often
ventricular tachyarrhythmias are diagnosed. At present,
clinical electrophysiologists are less than completely en-
chanted with the clinical relevance of sinus node function
studies. Careful analysis of the electrocardiogram is ex-
tremely useful in providing significant clues to the abnormal
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rhythm (Fig . 2). Typi cally , in patients with suspected se-
rious bradyarrhythmias a minimal study would first include
an evaluation of the susceptibility of the sinus node to " ov-
erdrive suppression. " By convention, the high right atrium
in the region of the sinus node is paced for I minute at each
of several rates. Measurements include the time of return
of the first sinus beat from the last paced atrial beat (that
is, sinus node recovery time , normally less than 1.5 seconds)
and the corrected sinus node recovery time ("corrected"
by subtracting the cycle length of the patient's intrinsic
spontaneous sinus rate from the sinus node recovery time,
normally less than 550 ms) . However. it is unlikel y that
one would want to attribute symptoms to any pause less
than 2 to 3 seconds in duration. After cessation of pacing ,
sinus node automaticity usually' 'warms up" and the sinus
rate returns to baseline over the first few beats; a more erratic
pattern usually indicates sinus node exit block.
A second evaluation ofsinus node fun ction involves some
measure of the so-called sinoatrial condu ction time (nor-
mally less than 125 ms) , which presumably reflects the time
for an impul se originating in the sinus node to exit from the
perinodal tissue into the atrium. Although abnormalities
of perinodal conduction undoubtedly contribute to both
bradyarrhythmias (for example. sinus pauses, sinus exit block
and concealed reentry), the relevance of sinoatrial conduc-
tion time measurements in the management of patients with
brad yarrhythmias is unclear at present. Impro ved discrim-
inative power of electrophysiologic testing for sinus node
disease is currently under clinical investigation using drug
inhibition of autonomic and neural tone (for example , atro-
pine plus beta-receptor blockade [38]) . Thus the clinician ,
often faced with a galaxy of confusing and equivocal results ,
must continue to use his intuitive . mature experience to
properly recommend the implantation of a cardiac pace-
maker to appropriately selected patients .
Brady-tachycardia Syndrome
Patients demonstrating alternative paroxysmal brady- and
tachyarrhythmias have been identified with increasing f re-
quency (39,40) . Rapid heart action may result from the onset
of atrial fibrillat ion or atrial flutter , often preceded by atrial
premature depolarizations or default of sinus node activity,
or both . Hence , the ventricular rate may abruptly increa se
with the onset of atrial flutter or fibrillation, especially in
patients with an intact atrioventricular conduction system .
Often , tachyarrhythmias occur in association with chest dis-
comfort and dyspnea. With their abrupt cessation prolonged
bradycardia or asystole occurs. related to exaggerated ov-
erdrive suppression of abnormal pacemakers. In additi on .
alternation between bradyarrh ythmia and tachyarrhythmi a
may also reflect a common pathophysiologic mechani sm .
It has now been demon strated that both tachy- and brady-
arrhythmias may result from disorders of sinoatrial con-
duction (41) . Conduction delay in one portion of the path-
way connecting the sinus and perinodal fibers may cause
exit block and pauses; however. if conduction can occur in
another pathway. reentrant phenomena and tachyarrh yth-
mias may result (41). Detailed electrophysiologic studies
have also demonstrated prolonged atrial asystole due to re-
petitive concealed sinus-perinodal reentry (Fig. 5) (41). Hence.
it is not unexpected that sinus brad y- and tachyarrh ythm ias
are commonly associated.
Unfortunately, drugs that can be utilized to suppress
tachyarrhythmias, such as quinidine. digitalis , propranolol
and verapamil , may produce further depre ssion of sinus
node automaticit y or alternati vely sinoatrial conduction de-
lay, which may addit ionally aggrav ate the bradycardia por-
tion of this syndrome. Occasionally these agents may con-
tribute to cardiac arrest. especially if used in combination.
Thus, successful management often requires both pharma-
cologic and pacemaker therapy.
Bradycardia also has been reported to contribute to fatal
ventricular fibrillation in the subset of patients with a long
QT interval (42). It appears that a criticall y timed extra-
systolic coupling interval. as well as an alteration of re-
polarization due to the bradycardi a, may precipitate ven-
tricular fibrillation in certain circumstances. In such patients,
strict avoidance of clas s I antiarrhythmic drugs is indicated;
long-term pacemaker therapy may be indicated.
Bradycardia Produced by Atrioventricular
Conduction Disorders
An abundance of information has become available con-
cerning the pathology. electrophysiolo gy, anatomy and clin-
ical significance of disturbances of atrioventricular conduc-
tion. Although interest in this subject has been documented
since 1827. with a description by Adams (4) of syncope
associated with a slow heart rate, the ensuing years ushered
in a confusing number of eponyms and synonyms in the
classification of atrioventricular condu ction disturbances.
The issue heated up intensely in 1924when Mobitz classified
atrioventricular block according to rather preci se criteria
(43) . In 1963. Lenegre and Moreau (44) and Lev (45) ini-
tiated the detailed anatomic studies that led to the more
current concepts of intraventricular conduction disturb-
ances. More recently. Rosenbaum and co-workers (46,47)
offered a logical classifi cation of block within the fascicle s
of the Purkinje system and described a bradycardia-depen-
dent phase 4 bundle branch block and also contrasted it to
the tachycardia-dependent variety which invoked a phase 3
block. By the mid I960s several investigators had explored
the electrophysiologi c mechanisms of atrioventricular con-
duction delay at the cellul ar level (48- 5 1). and Damato et
al. (52). using His bundle recordings, described the clinical
electrophysiologic mechanisms associat ed with atrioven-
tricular conduction delay and block.
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Prognosis. The anatomic location of the block, rather
than the variation or constancy of the PR interval, largely
determines the clinical significance of the block (53). Neu-
rologic or cardiac symptoms are invariably present in pa-
tients with second degree or complete atrioventricular heart
block associated with QRS complexes of 120 ms or greater
in contrast to patients with narrow QRS complexes. Prog-
nosis and the decision to implant a pacemaker should there-
fore be based primarily on the location of the block rather
than on the behavior of the PR interval (for example, Mobitz
type I [Wenckebach] or Mobitz type 11 block) (54). There
are also instances in which concealed reentry or concealed
discharge of a junctional pacemaker will give the illusion
of a Mobitz type 11 block unless His bundle electrograms
are available for study (55,56). However, the occurrence
of a so-called split His bundle recording may offer a poor
prognosis even though the QRS complexes remain narrow.
It is now generally accepted that patients showing at least
second degree atrioventricular block with wide QRS com-
plexes will invariably require cardiac pacing because very
few are free from significant symptoms at the time the block
is identified (54,56-58).
Significance of prolonged HV interval. The decision
to insert a cardiac pacemaker in chronic subjunctional con-
duction disorders is largely based on the presence of second
degree and higher grades of atrioventricular block with wide
QRS complexes. Additionally, early workers recording His
bundle electrograms suggested that patients with bundle branch
block and increased HV interval would be at high risk for
progression of the conduction disease. Subsequent studies
(57,58) have indicated that high morbidity and mortality
rates occurred only in patients with symptomatic heart dis-
ease and that sudden cardiac death was a major cause of
mortality in patients with chronic bifascicular block. How-
ever, this association of sudden death was clearly linked
with the presence of coronary heart disease and ventricular
arrhythmias, and suggested that ventricular fibrillation was
the most frequent mechanism for sudden death (57). In
comparison, the mortality attributed to either bradyarrhyth-
mias or heart block was minimal. These findings have been
further substantiated by McAnulty et al. (58). Unfortu-
nately, His bundle recordings in patients with chronic bi-
fascicular block in which the HV interval is either normal
or only mildly prolonged have not offered reasonable as-
Figure 5. Apparent sinus bradycardia due to concealed sino-perinodal
reentry resulting in failure of atrial activation. The figure is arranged as
follows: Top: microelectrode recordings from the sinus node and perinodal
fibers. and electrogram recorded in the region of the interatrial septum.
Bottom: A Lewis-type diagram indicating the mechanism. Arrows point
to local responses in the region of the sinus fibers produced by concealed
reentry from the perinodal fiber into the sinus node region. The rhythmicity
of the sinus node is depressed (action potentials 4 and 7). PNF = perinodal
fibers; SEP = interatrial septum; SN =sinus node.
surance that serious complications would not occur in the
future. In fact, patients with a prolonged (>55 ms) or a
greatly prolonged (>75 ms) HV interval have no greater
risk of death potentially attributable to either heart block or
bradyarrhythmias than do patients with a normal HV interval
(58). Prophylactic pacing then would probably not modify
the clinical course in patients with chronic bifascicular block
and marked HV prolongation in the absence of clinical
symptoms due to bradycardia. In addition. asymptomatic
patients with bifascicular block do not routinely need elec-
trophysiologic testing and, furthermore, do not require pro-
phylactic cardiac pacing or evaluation before general surgery.
Bradycardia in Acute Myocardia/Infarction
Sinus bradycardia. Bradyarrhythmias resulting from
either direct sinus node dysfunction or afferent impulses that
engender vagotonic influences in the presence of an acute
myocardial infarction are not uncommon. Most often, oc-
clusion of the right coronary artery (or dominant circumflex
vessel) with a resultant inferior wall myocardial infarction
is associated with periods of severe sinus bradycardia; with
proper treatment, this complication carries an excellent
prognosis. These events should be clearly distinguished from
the many occasions on which slow sinus rhythm or slow
idioventricular mechanisms are an agonal mechanism as-
sociated with major cardiovascular catastrophes. In one doc-
umented study, Myerburg et al. (59) noted that bradyar-
rhythmias or asystole were found in 31% of patients with
pre-hospital cardiac arrest. Furthermore, the ultimate prog-
nosis of patients with cardiac arrest who were initially iden-
tified with sinus arrest was poor and none of the patients in
this selected group survived. Often, however, in patients
resuscitated from cardiovascular collapse with asystolic or
severe bradycardia, the bradycardia is a reflex response to
a primary apneic, hypoxemic, pulmonary, central nervous
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system or vagal stimulu s. In such cases, resuscitation and
ultimate survival reflect more the underlying process and
time elapsed before the start of resuscitation than the pres-
ence of bradycardia. In patients with inferior wall myo-
cardial infarction and bradycardia the prognosis is usually
good. Acutely, bradycardia complicated by hypotension can
be managed by pacing , atrop ine or cautious use of a beta-
adrenergic sympathomimet ic amine with appropriate con-
comitant attention to reversible precipitating factors.
Patients with acute myocardial infarction and the so-
called bradycardia-hypotension syndrome (ventricular rate
less than 60 beat s/min and a systolic blood pressure of less
than 100 mm Hg) rarely require a temporary cardiac pace-
maker. A prompt response to intravenous infusion of atro-
pine and volume loading is usually sufficient to increase the
heart rate and blood pressure (60) . However, in some pa-
tients, sinus node dysfunction associated with an acute myo-
cardial infarction will persist and , in a few instances , require
permanent cardiac pacing (61).
Atrioventricular block. The appearance of second de-
gree atriove ntricular block of the type I variety (Wencke-
bach) or third degree block with narrow QRS complexes
usuall y does not require either temporary or permanent car-
diac pacing unless symptoms appear that can be related to
the bradycardia (62) . In contrast , the appearance of second
degree block of the Mobi tz type II pattern with wide QRS
complexes in the presence of an acute myocardial infarction
invariably require s the insertion of a temporary pacemaker.
This is because higher grades of block as well as exit block
from subsidiary pacem akers frequently occur and result in
inappropriate bradycardia and asystole (53,54, 62) . Persis-
tence of the type 11 block will invariably require permanent
pacing . Occas ionally . multipl e levels of block that involve
both the atrioventricular node and the His-Purkinje system
have been reported (13). Patient s with these findings will
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Figure 6. Lead II displaying sinus rhythm with frequent blocked atrial
premature systoles producing RR intervals of 1.5 seconds (rate = 40/mi n ).
require both temporary and permanent pacemakers. Simi-
larly, after open heart surgery, patients may demonstrate
sinoatrial node quiescence or atrioventri cular block , or both ,
for several hours to 2 weeks after the surgical procedure
and require temporary pacing during this period. A decision
for insertion of a permanent pacemaker should be delayed
until it can be established that the effects of surgery or
antiarrhythmic drugs have regressed .
Other Manifestations of Atrioventricular
Conduction Disorders
Supraventricular arrhythmias associated with concealed
atrioventricular conduction can produce significant periods
of bradycardia . Frequent . nonconducted atrial premature
systoles (Fig. 6) or repet itive concealment in the presence
of atrial flutter may produce symptomatic bradycardia (Fig.
7) (13) . Moreover. in the presence of atrioventricular con-
duction delay, even relatively late cycle atrial premature
beats may fail to be conducted to the ventricles . Likewise ,
bradycardia can be caused by persistent ventricular bige-
miny with retrograde conduction to the atria either depress-
ing and resetting the sinus node, or blocking but concealing
within the atrioventricular junction.
An abortive type I atrioventricular block with atrial reen-
try can also produce bradycardia (Fig. 8). Supraventricular
tachycardias associated with either atrioventricular conduc-
Figure 7. LeadV5 demonstrating grouped
beating. Sinus rhythm is interrupted by
runs of atrial flutter that spontaneously
terminate and end in either a sinus or an
atrioventricular junctional escape beat.
This record shows a variant of the so-
called brady-tachycardia syndrome, The
tachycardia was produced by paroxysmal
atrial flutter with short RR intervals. but
atrial flutter depressed the sinus node and
produced repetitiveconcealed conduction
in the atrioventricular node. causing pe-
riods of bradyarrhythmia.
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Figure 8. Orthogonal lead Y. Sinus rhythm
is present with first degree atrioventricular
block of 315 ms: an increase of the PR
interval to 360 ms permits an atrial echo
beat that depolarizes the atria but fails to
be conducted to the ventricle. This is an
example of the so-called abortive Wenck-
ebach phenomenon.
y
tion delay or concealed conduction may also present as part
of the' 'brady-tachycardia syndrome." Frequently, patients
with these findings do not require therapy unless there are
disabling symptoms due either to the bradycardia or to the
tachycardia. Suppressive drug therapy for tachycardia may
result in extreme bradycardia: consequently, a combination
of pharmacologic agents such as digitalis, beta-receptor
blocking drugs or verapamil may require the use of a cardiac
pacemaker in addition to the pharmacologic therapy (Fig.
9).
Pseudobradycardia. In addition to artifacts of the wave-
forms in the electrocardiogram, failure to detect a peripheral
pulse can give the illusion and symptoms of bradycardia
(33). Frequent premature atrial systoles that are conducted
to the ventricles but that do not result in adequate stroke
volume or ventricular premature systoles may also mimic
bradycardia (63). The bradycardia can be further aggravated
by the premature discharge of the sinus node with a depres-
sion of normal rhythmicity or nonconducted sinus impulses
resulting from concealed retrograde conduction into the
atrioventricular junction, or both. Other mechanisms of
pseudobradycardia include runs of supraventricular arrhyth-
mias, bigeminy, trigeminy or absolute mechanical alternans,
as well as manifestations of the so-called pacemaker syn-
drome with varying cardiac output (31).
management are required, and careful attention must be
directed to the proper selection of an optimal cardiac pace-
maker unit (30). With the advent of new and sophisticated
pacemaker circuits, it is often difficult for the clinician to
identify the optimal cardiac pacemaker for an individual
patient. Obviously, pacing that produces physiologic se-
quential atrioventricular contraction will be optimal. How-
ever, this cannot be easily achieved in many instances, and
some compromise must be reached to make the patient com-
fortable while providing protection from the adverse hemo-
dynamic consequences of the bradycardia. Specific indi-
cations for the use of so-called multiprogrammable and dual
chamber pacemakers are now evolving (64--67).
Pacemaker selection. No cardiac pacemaker should be
implanted for a bradyarrhythmia before certain basic clinical
data have been obtained. In general, the clinician should
select the simplest and best tolerated pacemaker circuit to
correct the bradyarrhythmia. Ventricular pacing may be sat-
isfactory in patients with persistent complete atrioventricular
block or in those in whom the bradycardia is episodic with-
out compromise in the blood pressure or cardiac output by
ventricular pacing. As described previously in detail (13),
hypotension may result from retrograde conduction of the
cardiac impulse with subsequent atrial activation and con-
traction during the period of ventricular systole. Usually,
the clinical decision can be made at the time of pacemaker
Management of the Bradyarrhythmias
Except for extreme sinus bradycardia associated with an
acute myocardial infarction or other transient events, the
use of pharmacologic agents such as atropine or isoproter-
enol is usually limited and without long-term effectiveness.
Consequently, more secure and dependable methods of
Figure 9. Upper strip: Lead II: Supraventricular tachycardia. present at
a rate of 154 beats/min. is followed by an irregular junctional escape rhythm
with long RR cycles representing the so-called brady-tachycardia syn-
drome. Lower strip: An atrioventricular sequential pacemaker was im-
planted with an atrioventricular interval of 150 ms and a return ventricular
cycle of 600 ms, which prevented the bradycardic events as well as inhibited
the atrioventricular junctional tachycardia.
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implantation. After introduction of the permanent ventric-
ular lead into the right ventricle, the effect of pacing on the
blood pressure should be evaluated during stimulation using
an external pacemaker. A decrease of more than 20 mm Hg
with prolonged pacing usually signals a potential pacemaker
syndrome and the surgeon should then implant an additional
right atrial electrode and use one of the atrioventricular
sequential dual chamber pacemakers (Fig. 9). Pacemakers
are available that can both sense and pace the atria or the
ventricle, or both. Physiologic variables can be programmed
into these units to pace the atria when the sinus rate falls
below a preset rate, such as 70 beats/min, and subsequently
to pace the ventricles when the atrioventricular interval ex-
ceeds a preset limit, such as more than 250 ms. Some units
can detect the onset of rapid atrial or ventricular rates and
make logical decisions to cease pacing or switch to other
modes, such as underdrive pacing or rapid overdrive or burst
pacing (64,65).
Atrial versus dual chamber pacemaker. Less sophis-
ticated pacemaker systems can be utilized to treat brady-
cardia associated with sinus node dysfunction. The use of
an atrial pacemaker is frequently sufficient, provided that
the integrity of the atrioventricular conduction system has
been investigated. The ability to pace the atria at a rate of
30 beats/min higher than the desired long-term pacing rate
without producing atrioventricular block is usually sufficient
to ensure adequate cardiac pacing in most persons. Although
diffuse conduction system disease involving both atrioven-
tricular conduction and sinus node dysfunction has been
described, many patients can be treated with a simple atrial
pacemaker. Atrial pacemaker units are not adequate, of
course, for patients who develop bradycardia during the
course of paroxysmal atrial fibrillation or flutter or in patients
with predominantly atrial fibrillation. Patients who develop
type I atrioventricular block (Wenckebach) at pacing rates
of less than 110 pulses/min should probably receive a dual
chamber pacemaker.
Indications for dual chamber pacemaker. Patients with
sinus node dysfunction and bradycardia who are only mildly
symptomatic may not need any therapy (9,10). However,
in patients who are also susceptible to paroxysmal tachyar-
rhythmias, the implantation of an atrioventricular sequential
pacemaker with a short atrioventricular interval and a pacing
rate of 80 to 100 beats/min may inhibit the onset of the
supraventricular tachycardias as well as protect against bra-
dycardia (Fig. 9) (64-66).
In another small subgroup of patients with high grade
atrioventricular block, coincidental linking of the ventricular
pacemaker rate with the intrinsic sinus rate may cause the
pacemaker syndrome when the P waves fall within the QRS-
ST segment of the ventricular paced beats. These patients
would also require dual chamber pacing. The implanting
surgeon can rule out this possibility at the time of the pace-
maker insertion simply by adjusting the ventricular pacing
rate to that of the atrial rate and recording the blood pressure.
A decrease of more than 20 mm Hg in blood pressure during
prolonged simultaneous atrial and ventricular contraction
would indicate that a dual chamber pacemaker is required
(Fig. 3).
Current problems. Not all of the possibilities of di-
agnosis and management can be covered in this brief review
of the bradyarrhythmias. However, to reiterate, excessive
use of pacemaker implantation should be avoided. It is pos-
sible that more than 25 to 30% of pacemakers implanted in
the United States are implanted without sufficient cause
(9.10). Furthermore, in an increasing number of instances,
the so-called pacemaker syndrome results from inappro-
priate .•match" of a cardiac pacemaker system to a patient's
particular electrophysiologic and hemodynamic require-
ments, thus compounding the problem of poorly conceived
and poorly designed patient care. Too often, the scenario
includes implantation of a nonindicated pacemaker with sub-
sequent aggravation of either symptoms or rhythm distur-
bances. This is costly and a disservice to the patient (31.65,66).
The medicolegal consequences of implanting a pacemaker
in patients with bradyarrhythmias when it is not indicated
or inserting an inappropriate unit in patients are beginning
to emerge (68). Thus. the development of more precise
methods for identifying and managing patients who require
cardiac pacemakers for bradyarrhythmias warrants further
evaluation.
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